SHARP PHILLIP A

Average Profitability
68.46%
Insider Buys Quantity
2
Insider Buys Sum
$399,964.42
Insider Sells Quantity
20
Insider Sells Sum
$91.52M

Insider Activity of SHARP PHILLIP A

According to the SEC Form 4 filings, SHARP PHILLIP A, being in a position of

  1. director at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30000 shares for $4.54M,
    over all time since 2012-02-21, has bought 28538 shares for $399,964, and sold 631186 shares for $62.29M.

The largest purchase of all time was on 2012-02-21 and amounted to 18604 shares of Alnylam Pharmaceuticals, Inc. for $199,993.

The largest sale of all time was on 2014-10-13 and amounted to 220000 shares of Alnylam Pharmaceuticals, Inc. for $18.7M.

Biography of SHARP PHILLIP A

No biography is available at this moment.

2024-02-29SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0241%
$151.34$4.54M+5.93%
2022-08-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
16,186
0.0132%
$230.71$3.73M-12.2%
2022-02-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0247%
$150.00$4.5M+27.46%
2020-11-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.026%
$124.89$3.75M+31.65%
2020-02-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0258%
$130.00$3.9M+1.36%
2019-11-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
15,000
0.0133%
$91.71$1.38M+40.9%
2019-04-15SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0275%
$88.23$2.65M-1.54%
2018-03-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.031%
$149.00$4.47M-35.36%
2018-03-09SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0291%
$129.00$3.87M-29.67%
2017-02-01SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
50,000
0.0572%
$39.80$1.99M+100.87%
2017-01-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.035%
$37.95$1.14M+112.64%
2017-01-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
30,000
0.0343%
$37.83$1.13M+107.21%
2015-12-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
60,000
0.0707%
$109.00$6.54M-39.9%
2014-10-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
director
220,000
0.2904%
$85.00$18.7M+20.46%
2013-01-22PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
9,934
0.0144%
$20.13$199,971+95.51%
2012-02-21PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
director
18,604
0.0361%
$10.75$199,993+41.4%
2008-07-21SaleBiogen Inc.
BIIB
director
72,500
0.0132%
$35.42$2.57M-27.26%
2008-04-08SaleBiogen Inc.
BIIB
director
99,900
0.0264%
$49.95$4.99M-22.7%
2004-05-14SaleBiogen Inc.
BIIB
director
294,100
0.088%
$58.96$17.34M+2%
2004-05-13SaleBiogen Inc.
BIIB
director
65,000
0.0039%
$11.73$762,450+2.02%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.